ENTERO HEALTHCARE ISSUE

Of the ₹33,610 crore raised by 37 companies so far in 2024, about 45%, or ₹15,190 crore, were through new shares, the highest proportion since 2015, when India Inc. raised nearly 48% fresh capital, according to data from primedatabase.com. The funds...

The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.

66 companies are set to see the lock-in period for pre-listing shareholders lifted between March 4 and June 29. This amounts to $21.1 billion in value terms. The value pertains to the total lock-up opening shares, but not all the shares may be sold,...

In the upcoming week, mainboard IPOs of Juniper Hotels and GPT Healthcare will hit the street to raise over Rs 2,000 crore. Meanwhile, SME companies Zenith Drugs and Dream Roll Tech are also scheduled to launch their issues.

Entero Healthcare's IPO debuted with a discount on BSE and NSE. Proceeds will be used for debt repayment, working capital, funding subsidiaries, and inorganic growth. The company has 73 warehouses and supply relationships with over 1,900 healthcare ...

Global private equity major Carlyle Group on Thursday sold 1.4% stake in private sector lender YES Bank for approximately Rs 1,057 crore.

In the unlisted market, the company's shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut at the bourses. The IPO comprised a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69...

To check the status of Entero Healthcare Solutions allotment through the registrar, which is Bigshare Services in this case, kindly follow the below steps.

Entero Healthcare IPO comprises a fresh equity issue of Rs 1,000 crore and an OFS of up to 47.69 lakh shares. Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, and Deepesh T Gala, among others, will offload shares under the OFS. T...

Entero Healthcare IPO price band has been fixed from Rs 1,195-1258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. the shares are trading with a marginal premium of Rs 5 in the grey market.

“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-...

The Street will see a flurry of listings, four of them in the mainboard segment. Three IPOs of Rashi Peripherals, Jana SFB and Capital SFB opened last week and closed for subscription. The listings of these three public offers are scheduled for next...

Incorporated in 2018 and founded by a former chief executive of Alkem Laboratories, Mumbai-based Entero Healthcare Solutions has grown to be among India's top three pharma distribution companies.

Entero Healthcare recorded a 31% YoY increase in revenue from operations during FY23, reaching Rs 3,300 crore. ICICI Securities, Dam Capital Advisors, Jefferies India, JM Financial, and SBI Capital Markets are the book running lead managers for the ...

The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.

Entero Healthcare IPO: The price band has been fixed in the range of Rs 1,195-1,258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for ...

​​Healthcare products distributors Entero Healthcare's IPO consists of a fresh issue of ₹1,000 crore and an offer for sale of 85.57 lakh shares. Prabhat Agrawal, OrbiMed Asia III Mauritius, and Prem Sethi are among the investors selling shares in th...

These four firms, which had filed their preliminary papers with the markets watchdog between June and October, obtained observation letters on January 16-19, an update with the Securities and Exchange Board of India (Sebi) showed on Thursday.

The company proposes to utilise the net proceeds from the offer towards the repayment of certain borrowings, working capital requirements, for general corporate purposes and to pursue inorganic growth initiatives through acquisitions.